Wuhan Keqian Biology Co.,Ltd Financials

Market Capitalization CN¥7.31 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	15.57
Forward PE	14.26
Price to Sales TTM	CN¥7.01
Price to Book MRQ	CN¥1.73
Enterprise to Revenue	5.41
Enterprise to EBITDA	10.63

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	45.31%
Operating Margin	53.43%
Return on Assets TTM	5.60%
Return on Equity TTM	11.41%

Income Statement

Revenue TTM	CN¥1,014,280,448
Revenue per Share TTM	CN¥2.16
Quarterly Revenue Growth	-5.40%
Gross Profit TTM	CN¥649,579,520
EBITDA	CN¥497,627,492
Net Income to Common TTM	CN¥459,541,056
Diluted EPS TTM	CN¥0.98
Quarterly Earnings Growth YoY	9.20%

Balance Sheet

Total Cash MRQ	CN¥1,721,455,360
Total Cash per Share MRQ	CN¥3.65
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.17
Current Ratio MRQ	5.30
Book Value per Share MRQ	CN¥8.84

Cash Flow

Operating Cash Flow TTM	CN¥435,305,056
Levered Free Cash Flow TTM	CN¥741,813,120

688526 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	466,128,056
Float Shares	115,311,345
Avg 10 Volume	1,925,060
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	74.18%
% Held by Institutions	1.34%

Stock Price Summary

Beta	0.42
Fifty Two Week Low	CN¥12.48
Fifty Two Week High	CN¥20.39
Fifty Two Week Change	11.66%
Day 50 MA	CN¥15.90
Day 200 MA	CN¥16.62

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.72
Forward Annual Dividend Yield	11.27%
Trailing Annual Dividend Rate	CN¥0.43
Trailing Annual Dividend Yield	2.82%
Payout Ratio	43.88%
Dividend Date
Ex Dividend Date	2025-06-16
Last Split Factor
Last Split Date